Development of a human vasopressin V<sub>1a</sub>-receptor antagonist from an evolutionary-related insect neuropeptide



Di Giglio, Maria Giulia, Muttenthaler, Markus, Harpsoe, Kasper, Liutkeviciute, Zita, Keov, Peter, Eder, Thomas, Rattei, Thomas, Arrowsmith, Sarah, Wray, Susan ORCID: 0000-0002-0086-1359, Marek, Ales
et al (show 4 more authors) (2017) Development of a human vasopressin V<sub>1a</sub>-receptor antagonist from an evolutionary-related insect neuropeptide. SCIENTIFIC REPORTS, 7 (1). 41002-.

Access the full-text of this item by clicking on the Open Access link.
[thumbnail of Sci Reports 2017 inotocin author proof.pdf] Text
Sci Reports 2017 inotocin author proof.pdf - Author Accepted Manuscript

Download (3MB)

Abstract

Characterisation of G protein-coupled receptors (GPCR) relies on the availability of a toolbox of ligands that selectively modulate different functional states of the receptors. To uncover such molecules, we explored a unique strategy for ligand discovery that takes advantage of the evolutionary conservation of the 600-million-year-old oxytocin/vasopressin signalling system. We isolated the insect oxytocin/vasopressin orthologue inotocin from the black garden ant (Lasius niger), identified and cloned its cognate receptor and determined its pharmacological properties on the insect and human oxytocin/vasopressin receptors. Subsequently, we identified a functional dichotomy: inotocin activated the insect inotocin and the human vasopressin V<sub>1b</sub> receptors, but inhibited the human V<sub>1a</sub>R. Replacement of Arg8 of inotocin by D-Arg8 led to a potent, stable and competitive V<sub>1a</sub>R-antagonist ([D-Arg8]-inotocin) with a 3,000-fold binding selectivity for the human V<sub>1a</sub>R over the other three subtypes, OTR, V<sub>1b</sub>R and V<sub>2</sub>R. The Arg8/D-Arg8 ligand-pair was further investigated to gain novel insights into the oxytocin/vasopressin peptide-receptor interaction, which led to the identification of key residues of the receptors that are important for ligand functionality and selectivity. These observations could play an important role for development of oxytocin/vasopressin receptor modulators that would enable clear distinction of the physiological and pathological responses of the individual receptor subtypes.

Item Type: Article
Uncontrolled Keywords: Animals, Humans, Ants, Neuropeptides, Receptors, Vasopressin, Recombinant Proteins, Amino Acid Substitution, DNA Mutational Analysis, Protein Binding, Antidiuretic Hormone Receptor Antagonists
Depositing User: Symplectic Admin
Date Deposited: 10 Feb 2017 10:38
Last Modified: 12 Oct 2023 15:53
DOI: 10.1038/srep41002
Open Access URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC52865...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3005710